NASDAQ: ERNA
Ernexa Therapeutics Inc Stock Ownership - Who owns Ernexa Therapeutics?

Insider buying vs selling

Have Ernexa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Charles Cherington10% Owner2026-02-104,000,000$0.50
$2.00MBuy
Charles Cherington10% Owner2025-06-0921,241,163$0.11
$2.23MBuy

1 of 1

ERNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ERNA insiders and whales buy or sell their stock.

ERNA Shareholders

What type of owners hold Ernexa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fidelity National Financial Inc3,295.01%38,430,766$478.85MInsider
Jeffrey Alan Berg1,791.29%20,892,428$260.32MInsider
Trinad Capital Master Fund Ltd763.08%8,900,093$110.90MInsider
Charles Cherington581.26%6,779,440$84.47MInsider
Joseph J. Farricielli Jr.579.13%6,754,611$84.16MInsider
Fidelity National Financial Inc 1455.09%5,307,911$66.14MInsider
Matthew Angel299.20%3,489,666$43.48MInsider
John D. Halpern250.92%2,926,551$36.46MInsider
Bleichroeder LP171.48%2,000,000$24.92MInstitution
Yiannis Monovoukas144.16%1,681,359$20.95MInsider

1 of 3

ERNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ERNA3.40%96.60%Net Buying
GDTC0.14%78.38%
MTVA0.21%99.79%Net Buying
CVKD3.18%38.44%Net Selling
BLRX0.00%0.39%

Ernexa Therapeutics Stock Ownership FAQ

Who owns Ernexa Therapeutics?

Ernexa Therapeutics (NASDAQ: ERNA) is owned by 306.46% institutional shareholders, 8,718.88% Ernexa Therapeutics insiders, and 0.00% retail investors. Fidelity National Financial Inc is the largest individual Ernexa Therapeutics shareholder, owning 38.43M shares representing 3,295.01% of the company. Fidelity National Financial Inc's Ernexa Therapeutics shares are currently valued at $478.85M.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.